Effect of Communicating health guidance and renal cardiovascular event risk-related items on health-related qOL and renal protection for diabetic patients with CKD

Effect of COmmunicating health guidance and renal cardiovascular event risk-related items on health-related qOL and renal protection for diabetic patients with CKD - Effect of COmmunicating health guidance and renal cardiovascular event risk-related items on health-related qOL and renal protection for diabetic patients with CKD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045590

Enrollment

Registered

2021-11-01

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes with CKD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.T2DM 2.eGFR 30-<60 3.Those who have voluntarily consented 4.Those who have undergone fundus photography within 12 months before the start of the test

Exclusion criteria

Exclusion criteria: 1.Those who are in the hospital or will be hospitalized 2.Those who are undergoing kidney transplantation or dialysis treatment 3.Those who plan to have a kidney transplant within the study period 4.Those who calculates "Lifestyle-related disease guidance management fee" 5.Those who get diabetes dialysis prevention guidance or nutritional guidance from a public health nurse or dietitian 6.Those who are pregnant or may become pregnant 7.Those who participated in clinical studies or clinical trials within 3 months before consent 8.Those who will move out of Kanazawa at the time of application in this research 9.Those who are judged to be inappropriate as a target by the judgment of a doctor

Design outcomes

Primary

Measure	Time frame
Changes in health-related QOL:Mainscale 26weeks	—

Secondary

Measure	Time frame
1.Changes in health-related QOL;Subscale 26weeks 2.Changes in renal function:eGFR 3.Changes in albuminuria 4.Continuation of proper hospital visits 5.Lifestyle related items Salt intake, abdominal circumference 6.Period leading to end-stage renal disease, new dialysis induction or transplantation, and new dialysis introduction,including Cr doubling, eGFR <15 mL / min / 1.73 m2, or death from renal failure as definitions of end-stage renal disease 7.Duration to onset or death of cardiovascular events 8.Changes in risk-related items (blood count, serum creatinine, AST, ALT, -GTP, TG, TC, HDL cholesterol, LDL cholesterol, FBS, HbA1c, urinary albumin	—

Measure

Time frame

1.Changes in health-related QOL;Subscale 26weeks 2.Changes in renal function:eGFR 3.Changes in albuminuria 4.Continuation of proper hospital visits 5.Lifestyle related items Salt intake, abdominal circumference 6.Period leading to end-stage renal disease, new dialysis induction or transplantation, and new dialysis introduction,including Cr doubling, eGFR <15 mL / min / 1.73 m2, or death from renal failure as definitions of end-stage renal disease 7.Duration to onset or death of cardiovascular events 8.Changes in risk-related items (blood count, serum creatinine, AST, ALT, -GTP, TG, TC, HDL cholesterol, LDL cholesterol, FBS, HbA1c, urinary albumin

—

Countries

Japan

Contacts

Public ContactTatsuyoshi Funasaka

NPO HEART null

funasaka-heart@fmail.plala.or.jp076-265-4031

Outcome results